NO307644B1 - Transdermalt, terapeutisk system med krystalliseringsinhibitor - Google Patents

Transdermalt, terapeutisk system med krystalliseringsinhibitor

Info

Publication number
NO307644B1
NO307644B1 NO941593A NO941593A NO307644B1 NO 307644 B1 NO307644 B1 NO 307644B1 NO 941593 A NO941593 A NO 941593A NO 941593 A NO941593 A NO 941593A NO 307644 B1 NO307644 B1 NO 307644B1
Authority
NO
Norway
Prior art keywords
therapeutic system
transdermal therapeutic
crystallization inhibitor
crystallization
inhibitor
Prior art date
Application number
NO941593A
Other languages
English (en)
Norwegian (no)
Other versions
NO941593D0 (cs
NO941593L (no
Inventor
Ralph Lipp
Jutta Riedl
Johannes-Wilhelm Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO941593D0 publication Critical patent/NO941593D0/no
Publication of NO941593L publication Critical patent/NO941593L/no
Publication of NO307644B1 publication Critical patent/NO307644B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO941593A 1991-10-31 1994-04-29 Transdermalt, terapeutisk system med krystalliseringsinhibitor NO307644B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4210711A DE4210711A1 (de) 1991-10-31 1992-03-27 Transdermale therapeutische systeme mit kristallisationsinhibitoren
PCT/EP1992/002478 WO1993008795A1 (de) 1991-10-31 1992-10-21 Transdermale therapeutische systeme mit kristallisationsinhibitoren

Publications (3)

Publication Number Publication Date
NO941593D0 NO941593D0 (cs) 1994-04-29
NO941593L NO941593L (no) 1994-04-29
NO307644B1 true NO307644B1 (no) 2000-05-08

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941593A NO307644B1 (no) 1991-10-31 1994-04-29 Transdermalt, terapeutisk system med krystalliseringsinhibitor

Country Status (14)

Country Link
EP (1) EP0610357B1 (cs)
JP (1) JP3526864B2 (cs)
AT (1) ATE158181T1 (cs)
AU (2) AU2895392A (cs)
CA (1) CA2120599C (cs)
DE (2) DE4210711A1 (cs)
DK (1) DK0610357T3 (cs)
ES (1) ES2106888T3 (cs)
FI (1) FI110061B (cs)
GR (1) GR3025237T3 (cs)
HU (1) HU227531B1 (cs)
NO (1) NO307644B1 (cs)
PT (1) PT101019B (cs)
WO (1) WO1993008795A1 (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE69401945T3 (de) * 1993-06-25 2004-09-02 Alza Corp., Palo Alto Einarbeitung eines poly-n-vinylamids in ein transdermales system
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
KR100301226B1 (ko) † 1995-06-07 2002-07-06 다우 케네드 제이. 17-데아세틸노르제스티메이트를단독으로또는에스트로겐과조합하여투여하기위한경피첩부제
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19829713C1 (de) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutisches System mit Zusatz von Perglanzpigmenten
DE19834006A1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
DE19843027A1 (de) * 1998-09-19 2000-03-23 Labtec Gmbh Neohesperidin DC als Kristallisationsinhibitor
MXPA02005292A (es) * 1999-11-29 2002-12-11 Lohmann Therapie Syst Lts Sistemas terapeuticos transdermicos que tienen estabilidad mejorada y su produccion.
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
BR0210516A (pt) * 2001-06-18 2004-10-05 Noven Pharma Distribuição intensificada de drogas em sistemas transdérmicos
ES2377932T3 (es) 2003-10-10 2012-04-03 Ferring Bv Formulación farmacéutica transdérmica para minimizar los residuos sobre la piel
EP1857103B1 (en) 2005-02-28 2018-10-24 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
US8871249B2 (en) 2008-02-27 2014-10-28 Hisamitso Pharmaceutical Co., Inc. Medicated patch
JP5546013B2 (ja) 2008-02-27 2014-07-09 久光製薬株式会社 貼付剤及び包装体
WO2009110351A1 (ja) 2008-03-03 2009-09-11 久光製薬株式会社 経皮吸収製剤
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US9980920B2 (en) 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤

Also Published As

Publication number Publication date
WO1993008795A1 (de) 1993-05-13
EP0610357B1 (de) 1997-09-17
JPH07506083A (ja) 1995-07-06
HUT72964A (en) 1996-06-28
NO941593D0 (cs) 1994-04-29
DE59208918D1 (de) 1997-10-23
AU2895392A (en) 1993-06-07
DE4210711A1 (de) 1993-05-06
FI942011A0 (fi) 1994-04-29
FI942011L (fi) 1994-04-29
ES2106888T3 (es) 1997-11-16
ATE158181T1 (de) 1997-10-15
NO941593L (no) 1994-04-29
EP0610357A1 (de) 1994-08-17
AU712692B2 (en) 1999-11-11
CA2120599C (en) 2003-04-15
PT101019A (pt) 1994-02-28
DK0610357T3 (da) 1998-05-11
GR3025237T3 (en) 1998-02-27
HU9401257D0 (en) 1994-08-29
JP3526864B2 (ja) 2004-05-17
AU1652997A (en) 1997-05-29
PT101019B (pt) 1999-10-29
HU227531B1 (en) 2011-07-28
CA2120599A1 (en) 1993-05-13
FI110061B (fi) 2002-11-29

Similar Documents

Publication Publication Date Title
NO307644B1 (no) Transdermalt, terapeutisk system med krystalliseringsinhibitor
DK0596903T3 (da) Transdermale, terapeutiske systemer.
MY109727A (en) Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
ATE200028T1 (de) Transdermale abgabe vorrichtung
DE68915413D1 (de) Anzeigevorrichtung mit aktiver Matrix.
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
ITTO960469A0 (it) Dispositivo per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
DE68924247D1 (de) Anzeigevorrichtung mit aktiver Matrix.
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
DK0794770T3 (da) Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning
DK0650359T3 (da) Transdermalt terapeutisk system med det aktive stof 17-beta-estradiol (vandfrit)
DE68917651D1 (de) Aktiv-Matrix-Anzeigevorrichtung.
DE59712215D1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination

Legal Events

Date Code Title Description
MK1K Patent expired